Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Access Bio Inc

+ Add to Watchlist

950130:KS

9,500 KRW 260 2.81%

As of 02:15:08 ET on 05/22/2015.

Snapshot for Access Bio Inc (950130)

Open: 9,290 Day's Range: 9,290 - 9,610 Volume: 398,651
Previous Close: 9,240 52wk Range: 8,800 - 15,800 1-Yr Rtn: -19.83%

Stock Chart for 950130

No chart data available.
  • 950130:KS 9,500
  • 1D
  • 1M
  • 1Y
9,240
Interactive 950130 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 950130

Current P/E Ratio (ttm) 128.8431
Estimated P/E(12/2015) 26.3929
Relative P/E vs. KOSPI -
Earnings Per Share (KRW) (ttm) 73.7331
Est. EPS (KRW) (12/2015) 359.9450
Est. PEG Ratio 0.2024
Market Cap (M KRW) 257,583.00
Shares Outstanding (M) 27.11
30 Day Average Volume 688,364
Price/Book (mrq) 4.2878
Price/Sale (ttm) 7.9411
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 950130

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 950130

Access Bio Inc. develops, manufactures, and markets in-vitro diagnostic (IVD) tests. The Company develops rapid diagnostic test (RDT) for Malaria and Pregnancy.

Choi Young-HoCEO/Rep DirectorKang Sang-HoonVP/CFO
Baek Seung-JaeExecutive Director
More Company Profile & Key Executives for 950130

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil